OnKure Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
OnKure Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q3 2024.
  • OnKure Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 3.34M shares, a 1.12% decline year-over-year.
  • OnKure Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 30.7M shares, a 25.2% increase from 2022.
  • OnKure Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 24.5M shares, a 35% increase from 2021.
  • OnKure Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 18.1M shares, a 795% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 3.34M -38K -1.12% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 33.4M +3.21M +10.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 33.4M +8.38M +33.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 30.7M +6.18M +25.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 3.38M -21.1M -86.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 30.2M +5.75M +23.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 25M +578K +2.36% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 24.5M +6.35M +35% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 24.5M +99.5K +0.41% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 24.5M +3.1M +14.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 24.5M +22.4M +1081% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 18.1M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 24.4M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 21.4M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 2.07M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.